These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16276578)

  • 21. GE Prize-winning essay. Why Old World monkeys are resistant to HIV-1.
    Stremlau M
    Science; 2007 Dec; 318(5856):1565-6. PubMed ID: 18063779
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cellular restriction factors that inhibit human immunodeficiency virus replication: new strategies in antiretroviral therapy].
    Moreno-Valencia Y; Alvarez-García LX; Vázquez-Pérez JA
    Rev Invest Clin; 2014; 66(4):359-68. PubMed ID: 25695302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein.
    Kaiser SM; Malik HS; Emerman M
    Science; 2007 Jun; 316(5832):1756-8. PubMed ID: 17588933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.
    Cho SJ; Drechsler H; Burke RC; Arens MQ; Powderly W; Davidson NO
    J Virol; 2006 Feb; 80(4):2069-72. PubMed ID: 16439564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
    Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
    J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.
    Grant M; Larijani M
    AIDS Res Ther; 2017 Sep; 14(1):44. PubMed ID: 28893290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restriction of feline retroviruses: lessons from cat APOBEC3 cytidine deaminases and TRIM5alpha proteins.
    Münk C; Hechler T; Chareza S; Löchelt M
    Vet Immunol Immunopathol; 2010 Mar; 134(1-2):14-24. PubMed ID: 19896724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guanine-adenine bias: a general property of retroid viruses that is unrelated to host-induced hypermutation.
    Müller V; Bonhoeffer S
    Trends Genet; 2005 May; 21(5):264-8. PubMed ID: 15851060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential sensitivity of porcine endogenous retrovirus to APOBEC3-mediated inhibition.
    Park SH; Kim JH; Jung YT
    Arch Virol; 2015 Aug; 160(8):1901-8. PubMed ID: 26016442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape.
    Simon V; Bloch N; Landau NR
    Nat Immunol; 2015 Jun; 16(6):546-53. PubMed ID: 25988886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family.
    Dang Y; Wang X; Esselman WJ; Zheng YH
    J Virol; 2006 Nov; 80(21):10522-33. PubMed ID: 16920826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance.
    Haché G; Mansky LM; Harris RS
    AIDS Rev; 2006; 8(3):148-57. PubMed ID: 17078485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research sheds light on HIV antibody questions.
    AIDS Alert; 2008 Oct; 23(10):119-20. PubMed ID: 18935688
    [No Abstract]   [Full Text] [Related]  

  • 35. Emerging drug targets for antiretroviral therapy.
    Reeves JD; Piefer AJ
    Drugs; 2005; 65(13):1747-66. PubMed ID: 16114975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cytidine deaminase AID exhibits similar functional properties in yeast and mammals.
    Rogozin IB; Pavlov YI
    Mol Immunol; 2006 Mar; 43(9):1481-4. PubMed ID: 16219354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.
    OhAinle M; Kerns JA; Malik HS; Emerman M
    J Virol; 2006 Apr; 80(8):3853-62. PubMed ID: 16571802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular restriction factors affecting the early stages of HIV replication.
    Perez O; Hope TJ
    Curr HIV/AIDS Rep; 2006 Feb; 3(1):20-5. PubMed ID: 16522255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F.
    Ulenga NK; Sarr AD; Thakore-Meloni S; Sankalé JL; Eisen G; Kanki PJ
    J Infect Dis; 2008 Aug; 198(4):486-92. PubMed ID: 18598197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.
    Romani B; Engelbrecht S; Glashoff RH
    Arch Virol; 2009; 154(10):1579-88. PubMed ID: 19669862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.